Nikkei hits 3-1/2-year low as investors flee equities; SoftBank Group tumbles

The Nikkei average shed 1.7 per cent to 16,726.55, a 3-1/2-year closing low, having reversed earlier gains in choppy trade.

AP
The Nikkei's volatility index fell 0.9 per cent to 56.12, remaining in the vicinity of Monday's nine-year peak of 60.86.
Japan's Nikkei share benchmark saw its lowest finish since November 2016 on Wednesday despite an overnight rally on Wall Street, as worries about the coronavirus outbreak eclipsed hopes that broad policy support would combat the economic fallout.

The Nikkei average shed 1.7 per cent to 16,726.55, a 3-1/2-year closing low, having reversed earlier gains in choppy trade.

The Nikkei's volatility index, a measure of investors' volatility expectations based on option pricing and considered a gauge of investor fear, fell 0.9 per cent to 56.12, remaining in the vicinity of Monday's nine-year peak of 60.86.


Adding to wariness were U.S. stock futures which slid 3.7 per cent in Asia, falling to their daily limit outside U.S. trade, a day after the S&P 500 climbed 6.0 per cent and the Dow gained 5.2 per cent.

Nikkei heavyweight SoftBank Group Corp plunged 10.9 per cent, taking its market cap below that of domestic mobile phone subsidiary SoftBank Corp for the first time.

The broader Topix edged up 0.2 per cent to 1,270.84, moving off a near four-year trough touched on Tuesday.
ADVERTISEMENT

Hopes of the Bank of Japan (BOJ) buying Exchanged Traded Funds (ETFs) more aggressively lent support to the broad market, traders said.

The BOJ bought a record 120 billion yen ($1.12 billion) of Japanese stock ETFs on Tuesday, even though the Topix index rose in the morning.

BOJ Governor Haruhiko Kuroda told parliament on Wednesday that at current Nikkei levels, latent losses on the BOJ's holdings of ETFs were likely around 2 trillion to 3 trillion yen ($19 billion to $28 billion).

Elsewhere, shares in Fujifilm Holdings Corp jumped by a daily limit of 15.4 per cent after a Chinese official said the company's Avigan anti-flu drug appeared to help coronavirus patients recover.
ADVERTISEMENT

Performance gaps between individual shares were among the widest in recent years. In the Topix core 30, the best performer, Kao Corp, climbed 7.4 per cent, while the worst, SoftBank Group, lost 10.9 per cent.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Text Size:AAA
Success
This article has been saved

*

+